Literature DB >> 30882720

Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania.

Khadija Said1,2,3, Jerry Hella1,2,3, Mwajabu Ruzegea1, Rajesh Solanki4, Magreth Chiryamkubi5, Francis Mhimbira1,2,3, Nicole Ritz3,6, Christian Schindler2,3, Anna M Mandalakas7, Karim Manji8, Marcel Tanner2,3, Jürg Utzinger2,3, Lukas Fenner9.   

Abstract

BACKGROUND: Childhood tuberculosis (TB) is acquired after exposure to an infectious TB case, often within the household. We prospectively screened children 6-59 months of age, exposed and unexposed to an infectious TB case within the same household, for latent tuberculosis infection (LTBI), in Dar es Salaam, Tanzania.
METHODS: We collected medical data and clinical specimens (to evaluate for helminths, TB and HIV coinfections) and performed physical examinations at enrollment and at 3-month and 6-month follow-up surveys. LTBI was assessed using QuantiFERON-TB Gold (QFT) at enrollment and at 3 months.
RESULTS: In total, 301 children had complete data records (186 with TB exposure and 115 without known TB exposure). The median age of children was 26 months (range: 6-58); 52% were females, and 4 were HIV positive. Eight children (3%) developed TB during the 6-month follow-up. We found equal proportions of children with LTBI among those with and without exposure: 20% (38/186) versus 20% (23/115) QFT-positive, and 2% (4/186) versus 4% (5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy, but 61% of parents/caregivers of children with unknown TB exposure and positive QFT refused isoniazid preventive therapy.
CONCLUSIONS: In this high burden TB setting, TB exposure from sources other than the household was equally important as household exposure. Nearly one third of eligible children did not receive isoniazid preventive therapy. Evaluation for LTBI in children remains an important strategy for controlling TB but should not be limited to children with documented TB exposure.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30882720     DOI: 10.1097/INF.0000000000002131

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Performance of a household tuberculosis exposure survey among children in a Latin American setting.

Authors:  J Coit; M Mendoza; C Pinedo; H Marin; S S Chiang; L Lecca; M Franke
Journal:  Int J Tuberc Lung Dis       Date:  2019-11-01       Impact factor: 2.373

Review 2.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

3.  Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.

Authors:  Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz
Journal:  Front Pediatr       Date:  2019-05-29       Impact factor: 3.418

4.  Tuberculosis Mortality in Children under Fifteen Years of Age: Epidemiological Situation in Colombia, 2010-2018.

Authors:  Laura Plata-Casas; Leandro González-Támara; Favio Cala-Vitery
Journal:  Trop Med Infect Dis       Date:  2022-06-25

5.  Distinct Risk Factors for Clinical and Bacteriologically Confirmed Tuberculosis among Child Household Contacts in a High-Burden Setting.

Authors:  Micaela Sandoval; Padma Swamy; Alexander W Kay; Pilar Ustero Alonso; Gloria Sisi Dube; Hypertia Hlophe-Dlamini; Anna M Mandalakas
Journal:  Am J Trop Med Hyg       Date:  2020-09-24       Impact factor: 3.707

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.